Brendan McAtamney, CEO of UDG Healthcare, details the company’s impressive growth in recent years, particularly in North America, across both their Sharp and Ashfield business units. He also expands on the company’s proactive M&A strategy as well as his vision for UDG Healthcare in the coming years. You were appointed to your current role as CEO nearly one year ago to the day. What has the transition period been like?
"Generally speaking, we have a simple three-lens approach to asset acquisition. First is the strategic fit of the capability, second is the financial return and third is the cultural fit, as we are a people-based company."